Evidence map›Paper›PMID 39207806›Full record

ArticleChemSusChem2025

Copper-Catalysed Synthesis of (E)-Allylic Organophosphorus Derivatives: A Low Toxic, Mild, Economical, and Ligand-Free Method.

Lucas Pagès, Gracjan Kurpik, Rosa Mollfulleda, Racha Abed Ali Abdine, Anna Walczak, Florian Monnier, Marcel Swart, Artur R Stefankiewicz, Marc Taillefer

Abstract read
In one paragraph

Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lucas PagèsICGM, Université Montpellier, CNRS, ENSCM, Montpellier, France.
Gracjan KurpikCenter for Advanced Technologies, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 10, 61-614, Poznań, Poland.
Rosa MollfulledaIQCC and Department of Chemistry, Universitat de Girona, c/M.A. Capmany 69, 17003, Girona, Spain.
Racha Abed Ali AbdineICGM, Université Montpellier, CNRS, ENSCM, Montpellier, France.
Anna WalczakCenter for Advanced Technologies, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 10, 61-614, Poznań, Poland.
Florian MonnierICGM, Université Montpellier, CNRS, ENSCM, Montpellier, France.
Marcel SwartIQCC and Department of Chemistry, Universitat de Girona, c/M.A. Capmany 69, 17003, Girona, Spain.
Artur R StefankiewiczCenter for Advanced Technologies, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 10, 61-614, Poznań, Poland.
Marc TailleferICGM, Université Montpellier, CNRS, ENSCM, Montpellier, France.ORCID https://orcid.org/0000-0003-2991-5418

Funding

Académie des Sciences de l'Institut de France, the ENSCM, the CNRS, and the Université de MontpellierAEI/MCIN PID2020-114548GB-I00AEI/MCIN PRE2021-097669GenCat 2021SGR00487National Science Centre of Poland PRELUDIUM 2022/45/N/ST4/00518
6 · The paper itself

Abstract

Organophosphorus compounds are fundamental for the chemical industry due to their broad applications across multiple sectors, including pharmaceuticals, agrochemicals, and materials science. Despite their high importance, the sustainable and cost-effective synthesis of organophoshoryl derivatives remains very challenging. Here, we report the first successful regio- and stereoselective hydrophosphorylation of terminal allenamides using an affordable copper catalyst system. This reaction offers an efficient protocol for the synthesis of (E)-allylic organophosphorus derivatives from various types of P-nucleophiles, such as H-phosphonates, H-phosphinates, and secondary phosphine oxides. Key advantages of this ligand-free and atom-economic strategy include low toxicity of the Cu-based catalyst, cost effectiveness, mild reaction conditions, and experimental simplicity, making it competitive with methods that use toxic and expensive Pd-based catalysts. In an effort to comprehend this process, we conducted extensive DFT calculations on this system to uncover the mechanistic insights of this process.

Indexed as

AllenesCatalysisCopperDFT calculationsHydrophosphorylation

Identifiers

PMID39207806
PMCPMC11739839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.